Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Studies and Practice

Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?

Abstract

Objective:

Data suggest that female obesity impairs uterine receptivity and increases the risk of fetal and neonatal mortality. We analyzed the reproductive outcomes of gestational carriers (GCs) undergoing donated oocytes and assisted reproductive technology according to body mass index (BMI).

Design:

A retrospective analysis of 163 GCs undergoing 226 in vitro fertilization (IVF) and embryo transfer cycles.

Methods:

GCs undergoing in vitro fertilization and embryo transfer cycles were analyzed and divided according to their BMI (healthy weight: 20−24.9 kg m–2 (n=77 in 114 cycles); overweight: 25−29.9 kg m2 (n=55 in 71 cycles); and obese: 30−35 kg m2 (n=31 in 41 cycles)). All GCs underwent a complete medical evaluation and were cleared for pregnancy before being selected. Overweight and obese GCs also underwent a metabolic screening, including an oral glucose tolerance test and lipid profile. The main outcomes measured were clinical pregnancy and live birth rates, antenatal and neonatal outcomes.

Results:

Clinical pregnancy and live birth rates were similar despite increasing BMI. There were no statistically significant differences in the implantation rates, clinical pregnancy rates or live birth rates per embryo transfer among patients in the three BMI groups. In the healthy weight, overweight and obese GCs, the clinical pregnancy rates per GC were 72%, 84% and 79%, and per embryo transfer rates were 52%, 49% and 56%, respectively; P=NS. The live birth rates per GC were 70%, 84% and 75%, and per embryo transfer rates were 50%, 49% and 53%, respectively; P=NS. Twin rates were similar between the groups (35%, 31% and 29%, respectively; P=NS). There were no differences in gestational diabetes, preterm admissions or cesarean section rates. Neonatal intensive care unit admissions were similar (11%, 13% and 12%, respectively; P=NS), and no maternal, neonatal or infant mortality occurred.

Conclusions:

These data show that increasing obesity does not impair the reproductive outcome in GC cycles. Larger sample size is indicated to verify these findings. Furthermore, this study suggests that the standard metabolic screening used for GCs may lead to selection of healthier patients compared with women of comparable BMI who conceive outside of a fertility clinic setting, indicating the metabolic profile, rather than BMI, may better explain differences in pregnancy outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. World Health Organization. Obesity and Overweight Fact Sheet No. 311. Updated January 2015. Available at http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed April 2015).

  2. Suresh A, Liu A, Poulton A, Quinton A, Amer Z, Mongelli M et al. Comparison of maternal abdominal subcutaneous fat thickness and body mass index as markers for pregnancy outcomes: a stratified cohort study. Aust N Z J Obstet Gynaecol 2012; 52: 420–426.

    Article  PubMed  Google Scholar 

  3. Stein C, Colditz GA . The epidemic of obesity. J Clin Endocrinol Metab 2004; 89: 2522–2525.

    Article  CAS  PubMed  Google Scholar 

  4. Harlass FE, Plymate SR, Fariss BL, Belts RP . Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 1984; 42: 649–652.

    Article  CAS  PubMed  Google Scholar 

  5. Hollmann M, Runnebaum B, Gerhard I . Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 1996; 11: 1884–1891.

    Article  CAS  PubMed  Google Scholar 

  6. Liat S, Cabero L, Hod M, Yogev Y . Obesity in obstetrics. Best Pract Res Clin Obstet Gynaecol 2015; 2979–2990.

  7. McDonald SD, Han Z, Mulla S, Beyene J Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010; 341: c3438.

    Article  Google Scholar 

  8. Aune D, Saugstad OD, Henriksen T, Tonstad S . Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA 2014; 311: 1536–1546.

    Article  CAS  PubMed  Google Scholar 

  9. Brewer CJ, Balen AH . The adverse effects of obesity on conception and implantation. Reproduction 2010; 140: 347–364.

    Article  CAS  PubMed  Google Scholar 

  10. Santangeli L, Sattar N, Huda S . Impact of maternal obesity on perinatal and childhood outcomes. Best Pract Res Clin Obstet Gynaecol 2015; 29: 438–448.

    Article  PubMed  Google Scholar 

  11. Lashen H, Fear K, Sturdee DW . Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case–control study. Hum Reprod 2004; 19: 1644–1646.

    Article  CAS  PubMed  Google Scholar 

  12. Centers for Disease Control and Prevention. Section 5: ART Trends 2002-2011. Available at http://www.cdc.gov/art/pdf/2012-report/national-summary/art_2012_national_summary_report.pdf (accessed 31 December 2014).

  13. Centers for Disease Control and Prevention. Section 2: ART cycles using fresh, nondonor eggs or embryos (part C). Available at http://www.cdc.gov/art/pdf/2012-report/national-summary/art_2012_national_summary_report.pdf (accessed 31 December 2014).

  14. Dar S, Lazer T, Swanson S, Silverman J, Wasser C, Moskovtsev SI et al. Assisted reproduction involving gestastional surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program. Hum Reprod 2015; 30: 345–352.

    Article  PubMed  Google Scholar 

  15. Anchan RM, Missmer SA, Correia KF, Ginsburg ES . Gestational carriers: a viable alternative for women with medical contraindications to pregnancy. Open J Obstet Gynecol 2013; 3: 24–31.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Practice Committee of ASRM and SART. Recommendations for practices utilizing gestational carriers: an ASRM Practice Committee guideline. Fertil Steril 2012; 97: 1301–1308.

    Article  Google Scholar 

  17. Goldenberg R, Punthakee Z . Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013; 37: S8–S11.

    Article  PubMed  Google Scholar 

  18. Bellver J, Busso C, Pellicer A, Remohi J, Simon C . Obesity and assisted reproductive technology outcomes. Reprod Biomed Online 2006; 12: 562–568.

    Article  PubMed  Google Scholar 

  19. Maheshwari A, Stofberg L, Bhattacharya S . Effect of overweight and obesity on assisted reproductive technology – a systematic review. Hum Reprod Update 2007; 13: 433–444.

    Article  CAS  PubMed  Google Scholar 

  20. Esinler I, Bozdag G, Yarali H . Impact of isolated obesity on ICSI outcome. Reprod Biomed Online 2008; 17: 583–587.

    Article  CAS  PubMed  Google Scholar 

  21. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R, SART Writing Group. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011; 26: 245–252.

    Article  PubMed  Google Scholar 

  22. Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003; 79: 1136–1140.

    Article  PubMed  Google Scholar 

  23. Cancello R, Clement K . Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113: 1141–1147.

    Article  CAS  PubMed  Google Scholar 

  24. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM . Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007; 166: 1312–1319.

    Article  PubMed  Google Scholar 

  25. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC . A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr 2009; 63: 78–86.

    Article  CAS  PubMed  Google Scholar 

  26. Jovanovic L, Knopp RH, Kim H, Cefalu WT, Zhu X-D, Lee YJ et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy. Diabetes Care 2005; 28: 1113–1117.

    Article  PubMed  Google Scholar 

  27. Styne-Gross A, Elkind-Hirsch K, Scott RT . Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril 2005; 83: 1629–1634.

    Article  PubMed  Google Scholar 

  28. Tamer Erel C, Senturk LM . The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol 2009; 21: 228–235.

    Article  PubMed  Google Scholar 

  29. Hutley L, Prins JB . Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 2005; 330: 280–289.

    Article  PubMed  Google Scholar 

  30. Karlsson C, Lindell K, Svensson E, Bergh C, Lind P, Billig H et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997; 82: 4144–4148.

    CAS  PubMed  Google Scholar 

  31. Agarwal SK, Vogel K, Weitsman SR, Magoffin DA . Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 1999; 84: 1072–1076.

    CAS  PubMed  Google Scholar 

  32. Llaneza-Suarez D, Llaneza P, González C, De-La-Fuente P, García-Ochoa C, Garrido P et al. Assessment of follicular fluid leptin levels and insulin resistance as outcome predictors in women undergoing in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2014; 102: 1619–1625.

    Article  CAS  PubMed  Google Scholar 

  33. Ethics Committee of the American Society of Reproductive Medicine. Consideration of the gestational carrier: a committee opinion. Fertil Steril 2013; 99: 1838–1841.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the Center for Surrogate Parenting, Inc., and The Surrogacy Center, LLC, for their participation in data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S R Lindheim.

Ethics declarations

Competing interests

The authors declare conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coyne, K., Whigham, L., O'Leary, K. et al. Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?. Int J Obes 40, 171–175 (2016). https://doi.org/10.1038/ijo.2015.159

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2015.159

This article is cited by

Search

Quick links